licensing Archives -

Roche hops on Bicycle’s drug discovery platform for cancer

https://pharmaphorum.com/news/roche-hops-on-bicycles-drug-discovery-platform-for-cancer/

Neurocrine signs $400M-plus deal with Idorsia for epilepsy drug

https://pharmaphorum.com/news/neurocrine-signs-400m-plus-deal-with-idorsia-for-epilepsy-drug/

Roche swoops on Dicerna’s gene-silencing hepatitis B drug

https://pharmaphorum.com/news/roche-swoops-on-dicernas-gene-silencing-hepatitis-b-drug/

Astellas cuts $795m deal with Pandion for type 1 diabetes drugs

https://pharmaphorum.com/news/astellas-biotech-deal-pandion-diabetes/

Novartis takes $80M punt on early-stage NASH drug from Pliant

https://pharmaphorum.com/news/novartis-takes-80m-punt-on-early-stage-nash-drug-from-pliant/

Alexion stalks rare disease drug from Stealth with $30m opt-in deal

https://pharmaphorum.com/news/alexion-stalks-rare-disease-drug-from-stealth-with-30m-opt-in-deal/

Labour government would use compulsory licensing for expensive drugs

https://pharmaphorum.com/news/labour-government-would-use-compulsory-licensing-for-expensive-drugs/

Genentech extends small-molecule R&D with three platform deals

https://pharmaphorum.com/news/genentech-extends-small-molecule-rd-with-three-platform-deals/

Eleven seals deal with Roche on eye drug pipeline

https://pharmaphorum.com/news/eleven-seals-deal-roche-eye-drug-pipeline/

Search